Skip to main content

Loncar China BioPharma ETF (CHNA)

NASDAQ: CHNA · Delayed Price · USD
+0.00 (0.00%)
After-hours:Sep 27, 2021 4:15 PM EDT
0.02 (0.06%)
At close: Sep 27, 4:00 PM
Expense Ratio0.79%
PE Ration/a
Shares Out400,000
Dividend (ttm)$0.16
Dividend Yield0.41%
Ex-Dividend DateDec 30, 2020
1-Year Return
Previous Close37.62
Day's Range37.30 - 37.64
52-Week Low29.11
52-Week High49.01
Inception DateAug 14, 2018

About CHNA

The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries. The fund is non-diversified.

Asset ClassEquity
IssuerExchange Traded Concepts
Stock ExchangeNASDAQ
Ticker SymbolCHNA
Index TrackedLCHINA index

Top 10 Holdings

23.35% of assets
Brii Biosciences Ltd Ordinary Shares2137.HK2.92%
CARsgen Therapeutics Holdings Ltd Ordinary Shares2171.HK2.61%
Hangzhou Tigermed Consulting Co Ltd Class HN/A2.54%
Pharmaron Beijing Co Ltd Ordinary Shares - Class HN/A2.28%
Wuxi AppTec Co LtdN/A2.24%
Innovent Biologics Inc1801.HK2.09%
Sino Biopharmaceutical Ltd1177.HK2.07%
WuXi Biologics (Cayman) Inc2269.HK2.04%
Austar Lifesciences Ltd Shs Reg S6118.HK2.03%
View More Holdings


Ex-DividendAmountPay Date
Dec 30, 2020$0.1546187Jan 4, 2021
Dec 23, 2019$0.04024942Dec 26, 2019
Full Dividend History


Best Biotech Stocks & ETFs for mRNA, Gene Editing

Here is what you should know about investing in these life changing technologies.

4 months ago - Zacks Investment Research

Best-Performing ETF Areas of Last Week

Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.

Other symbols:BDRYKURETAN
5 months ago - Zacks Investment Research

4 China ETFs Beating S&P 500 in its Worst Week Since 2008

Check these China ETFs that beat the S&P 500 in the past week, which was U.S. equities?

Other symbols:CHICKFYPKWEB
1 year ago - Zacks Investment Research

Best Pharmaceutical ETFs for Q1 2020

The best pharmaceutical ETFs for Q1 2020 are KURE, CHIH, and CHNA.

Other symbols:CHIHKURE
1 year ago - Investopedia

Why These Chinese Sector ETFs Are Crushing S&P 500 in 2019

Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.

2 years ago - Zacks Investment Research